Web Analytics

3 Latest Announced Rounds

  • $12,000,000
    Unknown
    Software Development
    May 2nd, 2025
  • $39,548,022
    Series C
    Medical Device
    May 2nd, 2025
  • $7,300,000
    Seed

    3 Investors

    Financial Services
    May 1st, 2025
$1,017.49M Raised in 43 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Evozyne

start up
United States - Chicago, IL
  • 28/09/2023
  • Series B
  • $81,000,000

Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein’s function based on the rules of nature, we address complex, high-impact problems. From developing life-changing patient treatments to making carbon capture a reality, Evozyne is committed to making a healthier, more sustainable world.


Related People

Mike GamsonFounder

Mike Gamson United States - Greater Chicago Area

I'm passionate about leading teams to pursue inspiring goals. I love working with intellectually curious people who can do anything, but show up everyday with humility and a drive to be better than they were yesterday. I believe that driving results matters as does taking the time in life to stop to smell the roses. I aspire to be a great colleague and I hope to be a student of new things forever.